These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 37903884)
1. Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study. Durán-Martínez M; Gómez-Dueñas G; Rodriguez-Ortíz L; Sanchez-Hidalgo JM; Gordón-Suárez A; Casado-Adam Á; Rufián-Peña S; Valenzuela-Molina F; Rufián-Andujar B; Vázquez-Borrego MC; Romero-Ruiz A; Briceño-Delgado J; Arjona-Sánchez Á Surg Endosc; 2024 Jan; 38(1):66-74. PubMed ID: 37903884 [TBL] [Abstract][Full Text] [Related]
2. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis. Shaltiel T; Solomon D; Pletcher ER; Golas BJ; Magge DR; Sarpel U; Labow DM; Cohen NA Surg Endosc; 2022 Aug; 36(8):6153-6161. PubMed ID: 35080674 [TBL] [Abstract][Full Text] [Related]
3. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches. Chang SC; Fingerhut A; Chen WT Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126 [TBL] [Abstract][Full Text] [Related]
4. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer. Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829 [TBL] [Abstract][Full Text] [Related]
5. Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer. Brault C; Brind'Amour A; de Guerke L; Auclair MH; Sideris L; Dubé P; Soucisse M; Tremblay JF; Bernard L; Piedimonte S; Fortin S Curr Oncol; 2023 Dec; 30(12):10272-10282. PubMed ID: 38132382 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy]. Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167 [No Abstract] [Full Text] [Related]
7. The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. Ortega J; Orfanelli T; Levine E; Konstantinidis IT Chin Clin Oncol; 2023 Apr; 12(2):16. PubMed ID: 36946185 [TBL] [Abstract][Full Text] [Related]
8. Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). Zambrano-Vera K; Sardi A; Lopez-Ramirez F; Sittig M; Munoz-Zuluaga C; Nieroda C; Gushchin V; Diaz-Montes T Ann Surg Oncol; 2021 Aug; 28(8):4655-4666. PubMed ID: 33393042 [TBL] [Abstract][Full Text] [Related]
9. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review. Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T Eur J Cancer; 2020 Mar; 127():76-95. PubMed ID: 31986452 [TBL] [Abstract][Full Text] [Related]
10. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. Rodríguez-Ortiz L; Arjona-Sánchez A; Ibañez-Rubio M; Sánchez-Hidalgo J; Casado-Adam A; Rufián-Peña S; Briceño-Delgado J Surg Endosc; 2021 Apr; 35(4):1778-1785. PubMed ID: 32328823 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056 [TBL] [Abstract][Full Text] [Related]
12. Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Chambers LM; Yao M; Morton M; Gruner M; Chichura A; Horowitz M; Costales AB; Rose PG; Michener CM; Debernardo R Gynecol Oncol; 2021 May; 161(2):389-395. PubMed ID: 33551202 [TBL] [Abstract][Full Text] [Related]
13. Laparoscopic Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis: Improved Short-term Outcomes Revealed Through Propensity Score Matching Analysis. Bortoli N; Tonello M; Pizzolato E; Cenzi C; Pilati P; Sommariva A J Gastrointest Cancer; 2024 Jun; 55(2):733-739. PubMed ID: 38224418 [TBL] [Abstract][Full Text] [Related]
14. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis. Cho CY; Veerapong J; Baumgartner JM; Murphy JD; Lowy AM; Kelly KJ Surg Endosc; 2023 Jul; 37(7):5644-5651. PubMed ID: 36477643 [TBL] [Abstract][Full Text] [Related]
15. Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). Munoz-Zuluaga CA; Sardi A; Sittig M; Gushchin V; King MC; Nieroda C; Lopez-Ramirez F; Diaz-Montes TP Int J Surg Oncol; 2020; 2020():1467403. PubMed ID: 33381312 [TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups. Gomes David M; Bakrin N; Salleron J; Kaminsky MC; Bereder JM; Tuech JJ; Lehmann K; Mehta S; Glehen O; Marchal F BMC Surg; 2022 Jan; 22(1):1. PubMed ID: 34996419 [TBL] [Abstract][Full Text] [Related]
18. Effect of the learning curve of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on the treatment of colorectal peritoneal metastasis. Chidambarasamy ES; Chia CS; Johnny Ong CA; Soo KC; Ching Teo MC; Ching Tan GH Asian J Surg; 2022 Jan; 45(1):339-345. PubMed ID: 34148748 [TBL] [Abstract][Full Text] [Related]
19. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer. Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658 [TBL] [Abstract][Full Text] [Related]
20. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Allievi N; Bianco F; Pisano M; Montori G; Fugazzola P; Coccolini F; Lotti M; Mosconi S; Merelli B; Campanati L; Lucianetti A; Ansaloni L; Magnone S Updates Surg; 2023 Jan; 75(1):159-167. PubMed ID: 36371549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]